---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-067531"
form_type: "8-K"
ticker: "CTMX"
cik: "0001501989"
company_name: "CytomX Therapeutics, Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:26:12.721758+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CytomX says SVB exposure immaterial; cash near FDIC limit, $917K letter of credit

## Summary
- Operating cash at SVB at or near FDIC-insured limit of $250,000.
- Standby letter of credit under office lease: ~$917,000 deposited at SVB.
- Third-party investments held at outside custodians, not directly exposed to SVB.
- Company does not consider SVB liquidity concern material to its operations.

## SEC filing metadata
- accession: 0001193125-23-067531
- form_type: 8-K
- ticker: CTMX
- cik: 0001501989
- company_name: CytomX Therapeutics, Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501989/000119312523067531/0001193125-23-067531-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501989/000119312523067531/d280737d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-067531
- JSON: https://secwatch.observer/filing/0001193125-23-067531.json
- Plain text: https://secwatch.observer/filing/0001193125-23-067531.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.